Biopharmaceutical Manufacturing, Upstream, Downstream ...
Biopharmaceutical Manufacturing, Upstream, Downstream processing news. News and analysis on the clinical development and manufacture of large molecule drugs. Aditum Bio and Leads …
‘Biotech remains the biopharma industry’s engine of innovation …
Jun 28, 2022 · Biotech performed ‘exceptionally well’ in 2021, driven by the COVID-19 crisis. That’s against a backdrop where the pandemic is projected to result in a cumulative reduction …
Trends in biosimilars: Regulatory approvals in 2024
Jul 24, 2024 · The global biosimilar market is estimated to reach a size of $43.8 billion by the end of 2024, and to grow over $100 billion in the next 10 years. Biologics are expensive …
All news - biopharma-reporter.com
EMA accepts Alvotech and Advanz Pharma’s Marketing Authorization Application for biosimilar of J&J’s Simponi. AbbVie acquires Aliada Therapeutics in $1.4 billion deal. Abzena announces …
Building resilience into biotech supply chains
Jul 8, 2022 · Biotech supply chains face an uncertain future in 2022 and beyond: up against myriad challenges ranging from future pandemic outbreaks to geopolitical tensions – and, …
Building a biotech hub: Switzerland focuses on mRNA, CGT and …
Sep 8, 2021 · There are 314 biotech companies in Switzerland: broken down into 251 developers and 63 suppliers. Swiss life science exports were valued at CHF 99.1bn ($108bn USD) in …
Speed, flexibility and innovation: Rethinking the way the …
Nov 29, 2021 · CRB’s newly released biopharma market outlook: Horizons: Life Sciences , is fueled by survey insights from more than 500 pharma representatives on key issues facing …
Opportunities for US manufacturing in biologics
Aug 3, 2021 · There’s an opportunity for the US to lead in advanced biologicals; as well as manufacturing in viral vectors and cell and gene therapies, according to CPhI’s insight’s report …
Aptamer partners with Hong Kong biotech to develop targeted …
Jan 31, 2023 · UK based, Aptamer Group, and Hong Kong headquartered, BaseCure Therapeutics, are paring up on the development of Optimer-targeted gene therapies. …
Spend, spend, spend: How biopharma consumable suppliers invested ...
Nov 17, 2021 · The company, which strengthened its presence in bioprocessing through the acquisition of GE’s biopharma unit, provides a wide range of consumables such as single-use …